ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1531	51	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
679	This is a comment on X from Rose Han IBRX ImmunityBio Initiated with a Buy Rat	End2War	1	10/23/2024
678	Maybe OT, but doesn't this concern you? EF Hutton ... livemint.com	waitwatchwander	-	10/23/2024
677	If anyone has the full report please share. Curious how they get to $30, which t	TinfoilHat	4	10/23/2024
676	Saw that. Hopefully a beginning of a trend.	Davidoff	-	10/23/2024
675	FWIW DJ ImmunityBio Initiated at Buy by EF Hutton ImmunityBio Price Target A	bgscolt	3	10/23/2024
674	With todays withdraw of Gilead's drug Trodelvy for bladder cancer would that	bgscolt	1	10/18/2024
673	What happened to your DBGI?	Davidoff	-	10/18/2024
672	That is next level stuff. In the short term, I have no doubt Merck and others w	ghettogoulash	-	10/17/2024
671	Interesting reddit.com	erippetoe	4	10/11/2024
670	It normally takes time to see significant order flow for new drugs, even if ther	End2War	-	10/3/2024
669	The question is, what constitutes substantial revenue in IBRX terms? In my opini	Huggenberg	-	10/2/2024
668	Consistent with what you guys are saying, I just want to mention that Adcock spo	End2War	2	9/30/2024
667	Temporary J-codes can be difficult for the medical billing process for a number	Redman1234	2	9/29/2024
666	Why would temporary vs permanent billing codes matter so much with a life extend	waitwatchwander	1	9/28/2024
665	Thank you Tin. I agree.	Redman1234	-	9/28/2024
664	Great post, and seemingly aligns with the smoke signal I proposed in my last pos	TinfoilHat	2	9/28/2024
663	Anktiva received FDA approval on April 22, 2024. C codes are temporary pricing	Redman1234	3	9/28/2024
662	I have more than enough right now. I just want this company to show us that it	jargonweary	3	9/27/2024
661	I have been adding under $4.00. Looks like market is pushing higher and IBRX is	End2War	2	9/27/2024
660	Nice close	erippetoe	-	9/26/2024
659	At first glance a potential new investor who hadn’t done their dd might be hesit	Redman1234	5	9/22/2024
658	SeekingAlpha latest article. ImmunityBio: Anktiva Launch, Good Data, Low Cash,	Redman1234	-	9/22/2024
657	It's pretty amazing how far along Chatgpt has come in the past year or so. I	ghettogoulash	-	9/18/2024
656	So an average of 6 million in sales approximately for 2024 is probably not going	zagnut1	-	9/17/2024
655	"Dude, IBRX is burning $130M per quarter. What's your point?" The	End2War	2	9/17/2024

Go to reply# or date (mm/dd/yy):